Business
Mesoblast (ASX:MSB) share price tumbles 8% giving back most of yesterday’s gains
Image source: Getty Images
The Mesoblast Ltd (ASX: MSB) share price was in reverse today after surging more than 11% on Monday. The allogeneic cellular medicines company announced a trial update to its rexlemestrocel-L drug.
At the closing bell, Mesoblast shares finished the day down 8.68%…
Continue Reading
-
Noosa News24 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General11 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business14 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News18 hours ago28 years later: Grim reality for single house hunters revealed